GSK offers $1 billion to raise stake in Indian unit

The UK-listed group offers to raise its stake in GlaxoSmithKline Pharmaceuticals, its Indian drug unit, boosting its investment in the country.

Denise Wee

December 16, 2013

GlaxoSmithKline (GSK) on Monday became the latest multinational to boost its investments in India, with a £629 million ($1 billion) offer to increase its stake in its India-listed drug unit

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

M&A
Banks
South Asia

#gsk
#hsbc